Education
About Us
Working with TipRanks
Follow Us
Genscript Biotech Corporation (HK:1548)
:1548
See the Price Targets and Ratings of:
1548 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
HK$20
Hold
16.41%
Upside
Reiterated
07/30/25
The overall score reflects a strong technical outlook buoyed by recent price momentum, but is significantly weighed down by valuation concerns, notably the negative P/E ratio. Financial performance shows promising growth and stability in balance sheet but is undermined by ongoing profitability and cash flow challenges. Investors should be cautious of the high valuation and focus on operational improvements and profitability for long-term success.
Unknown AnalystMorgan Stanley
Not Ranked
Morgan Stanley
HK$18.6→HK$21.9
Buy
27.47%
Upside
Reiterated
03/14/25
We lift our PT for GenScript and maintain our OW rating on the company due to three things: 1) GenScript's leading-edge technology platform and industry position in protein and the gene synthesis area with limited qualified competitors; 2) recovery order trend in the CRO and CDMO segments with eased geopolitical overhangs, and 3) outperforming enzyme business thanks to growing wallet share from key account clients as well as accelerated ex-China market expansion.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
HK$20
Hold
16.41%
Upside
Reiterated
07/30/25
The overall score reflects a strong technical outlook buoyed by recent price momentum, but is significantly weighed down by valuation concerns, notably the negative P/E ratio. Financial performance shows promising growth and stability in balance sheet but is undermined by ongoing profitability and cash flow challenges. Investors should be cautious of the high valuation and focus on operational improvements and profitability for long-term success.
Unknown AnalystMorgan Stanley
Not Ranked
Morgan Stanley
HK$18.6→HK$21.9
Buy
27.47%
Upside
Reiterated
03/14/25
We lift our PT for GenScript and maintain our OW rating on the company due to three things: 1) GenScript's leading-edge technology platform and industry position in protein and the gene synthesis area with limited qualified competitors; 2) recovery order trend in the CRO and CDMO segments with eased geopolitical overhangs, and 3) outperforming enzyme business thanks to growing wallet share from key account clients as well as accelerated ex-China market expansion.
Best Analysts Covering Genscript Biotech
1 Month
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
3 Months
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
1 Year
Unknown AnalystMorgan Stanley
Not Ranked
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a buy rating 5 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
1548 Analyst Recommendation Trends
Rating
May 24
Mar 25
May 25
Jun 25
Jul 25
Strong Buy
3
3
2
1
0
Buy
0
0
0
0
0
Hold
0
0
1
2
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
6
Each month's total comprises the sum of three months' worth of ratings.
1548 Stock Forecast FAQ
What is HK:1548’s average 12-month price target, according to analysts?
Based on analyst ratings, Genscript Biotech Corporation’s 12-month average price target is 16.01.
What is HK:1548’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1548, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Genscript Biotech Corporation a Buy, Sell or Hold?
Genscript Biotech Corporation has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Genscript Biotech Corporation’s share price target?
The average share price target for Genscript Biotech Corporation is 16.01. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$16.01 ,and the lowest forecast is HK$16.01. The average share price target represents -6.80% Decrease from the current price of HK$17.18.
The highest analyst share price target is HK$16.01 ,and the lowest forecast is HK$16.01. The average share price target represents -6.80% Decrease from the current price of HK$17.18.
What do analysts say about Genscript Biotech Corporation?
Genscript Biotech Corporation’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Genscript Biotech Corporation?
To buy shares of HK:1548, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.